Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (651-660 of 726) with videos related to

Pageof 73
Sort By:
ACS Chemical Neuroscience|April 7, 2020
Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide <i>cyclo</i>[Pro-Sar-Phe-d-Phe]: A Mixed Opioid Receptor Agonist-Antagonist Following Oral AdministrationMichael J Ferracane, Ariana C Brice-Tutt, Jeremy S Coleman, et al.
British Journal of Pharmacology|June 21, 2020
Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviourAriana C Brice-Tutt, Lisa L Wilson, Shainnel O Eans, et al.
Journal of Personalized Medicine|July 27, 2022
A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©Matthew G Davey, Amirhossein Jalali, Éanna J Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2007
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphomaM J Overman, L Feng, B Pro, et al.
Psychological Medicine|August 31, 2023
Peripheral inflammation associated with depression and reduced weight loss: a longitudinal study of bariatric patientsAnna P McLaughlin, Ellen Lambert, Rebecca Milton, et al.
Oncology (Williston Park, N.Y.)|August 30, 2002
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trialA H Sarris, A Phan, A Goy, et al.
The American Journal of Psychiatry|February 17, 1998
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsK Y Little, D P McLaughlin, L Zhang, et al.
Seminars in Oncology|February 28, 2001
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphomaP McLaughlin, F B Hagemeister, M A Rodriguez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 27, 2018
Recommendations on multidisciplinary management of elective surgery in people with haemophiliaM A Escobar, A Brewer, H Caviglia, et al.
Lung|June 8, 2014
The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registryRob G Stirling, S M Evans, P McLaughlin, et al.
Pageof 73

Showing results (651-660 of 726) with videos related to

Sort By:
Pageof 73
ACS Chemical Neuroscience|April 7, 2020
Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide <i>cyclo</i>[Pro-Sar-Phe-d-Phe]: A Mixed Opioid Receptor Agonist-Antagonist Following Oral AdministrationMichael J Ferracane, Ariana C Brice-Tutt, Jeremy S Coleman, et al.
British Journal of Pharmacology|June 21, 2020
Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviourAriana C Brice-Tutt, Lisa L Wilson, Shainnel O Eans, et al.
Journal of Personalized Medicine|July 27, 2022
A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©Matthew G Davey, Amirhossein Jalali, Éanna J Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2007
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphomaM J Overman, L Feng, B Pro, et al.
Psychological Medicine|August 31, 2023
Peripheral inflammation associated with depression and reduced weight loss: a longitudinal study of bariatric patientsAnna P McLaughlin, Ellen Lambert, Rebecca Milton, et al.
Oncology (Williston Park, N.Y.)|August 30, 2002
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trialA H Sarris, A Phan, A Goy, et al.
The American Journal of Psychiatry|February 17, 1998
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsK Y Little, D P McLaughlin, L Zhang, et al.
Seminars in Oncology|February 28, 2001
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphomaP McLaughlin, F B Hagemeister, M A Rodriguez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 27, 2018
Recommendations on multidisciplinary management of elective surgery in people with haemophiliaM A Escobar, A Brewer, H Caviglia, et al.
Lung|June 8, 2014
The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registryRob G Stirling, S M Evans, P McLaughlin, et al.
Pageof 73